Literature DB >> 10450217

Fulminant cytomegalovirus colitis complicating Staphylococcus aureus septicaemia and multiorgan failure in a previously immunocompetent patient.

K Grimsehl1, R A Seaton, M R Checketts.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10450217      PMCID: PMC1297065          DOI: 10.1177/014107689909200208

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Cytomegalovirus infection in patients with bacterial sepsis.

Authors:  M Ho
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

Review 2.  Severe cytomegalovirus infection in immunocompetent patients.

Authors:  M Eddleston; S Peacock; M Juniper; D A Warrell
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

3.  High incidence of active cytomegalovirus infection among septic patients.

Authors:  A S Kutza; E Muhl; H Hackstein; H Kirchner; G Bein
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

Review 4.  Gastrointestinal cytomegalovirus disease.

Authors:  R W Goodgame
Journal:  Ann Intern Med       Date:  1993-11-01       Impact factor: 25.391

  4 in total
  3 in total

Review 1.  Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts.

Authors:  Polymnia Galiatsatos; Ian Shrier; Esther Lamoureux; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

2.  Human cytomegalovirus infection of a severe-burn patient: evidence for productive self-limited viral replication in blood and lung.

Authors:  Klaus Hamprecht; Mathias Pfau; Hans-Eberhard Schaller; Gerhard Jahn; Jaap M Middeldorp; Hans-Oliver Rennekampff
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Cytomegalovirus enteritis causing ileal perforation in an elderly immunocompetent individual.

Authors:  Jae Myung Cha; Joung Il Lee; Jae Won Choe; Kwang Ro Joo; Sung Won Jung; Hyun Phil Shin; Sung Il Choi
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.